Due to the presence of common coding mutations and/or fusions genes (ETV6-RUNX1, E2A-PBX1, BCR-ABL, etc.)within subgroups of patients, it has been reported that hematologic malignancies have more shared neoantigens than most solid tumors [24,65]. This evidence concerns the gene RUNX1 and hematologic disorder.